CCM Investment Group’s AbbVie ABBV Stock Holding History

CCM Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$6.54M	Buy	31,860 +8,823	+38%	+$1.72M	0.69%	17
2024 Q4	$4.06M	Buy	+23,037	New	+$4.24M	0.44%	51

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CCM Investment Group's ABBV Position: Q1 2025 in Review

CCM Investment Group increased its AbbVie (ABBV) stake by 38% in Q1 2025, buying an estimated $1.72M and bringing the position to 31,860 shares worth $6.54M. The position accounts for 0.69% of the portfolio, ranked #17.

CCM Investment Group first reported a position in ABBV in Q4 2024 and has held it in 2 quarters since. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

CCM Investment Group held 31,860 shares of AbbVie worth $6.54M as of Q1 2025.
CCM Investment Group bought 8,823 AbbVie shares in Q1 2025, an estimated $1.72M.
AbbVie made up 0.69% of CCM Investment Group's portfolio in Q1 2025, its #17 holding.
CCM Investment Group first reported a position in AbbVie in Q4 2024 and has held it in 2 quarters since.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on CCM Investment Group's 13F filing for Q1 2025, filed 12 May 2025.